回盛生物(300871.SZ):獲得獸藥GMP證書和獸藥生產許可證
格隆匯7月6日丨回盛生物(300871.SZ)公佈,公司於近日收到湖北省農業農村廳核發的《獸藥GMP證書》和《獸藥生產許可證》。上述證書通過認證的生產線為位於武漢市東西湖區東西湖大道油紗路52號的粉劑/預混劑(2條)。
公司位於武漢市東西湖區東西湖大道油紗路52號的粉劑/預混劑(2條)通過獸藥GMP驗收並獲得《獸藥GMP證書》和《獸藥生產許可證》,有利於提高公司產品的產能水平和生產能力,為公司銷售規模和市場地位的提升奠定基礎;有利於提升公司自動化生產水平,有效提高勞動生產率,進一步提高公司產品的質量穩定性,消除不確定因素。上述生產線對應產品尚未取得獸藥產品批准文號,公司正在積極推進相關產品批准文號申報工作。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.